ARCHIVES

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

This article is from The Cancer Letter archive.

Vol. 01 No. 14 | April 4, 1975

Download PDF Visit The Full Archive

Related Articles

2,000 Breast Cancer Recurrence Biomarker Candidates Discovered

August 31, 2012

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

Government Offers Two Approval Standards For Assays: CLIA, FDA

January 30, 2009

Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million

April 12, 1985

Federal Regs Prohibit RFP Budget Releases

February 21, 1975

In Brief: NCAB Dec. Meeting Includes Biologics Symposium; Epidemiology Center Grant Program Disapproved

November 29, 1985